Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022

Daniel Busby Downgraded (VRCA) to Hold and Decreased Target to $4 on, May 25th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-4-on-may-25th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Daniel Busby of RBC Capital, Downgraded "Verrica Pharmaceuticals Inc." (VRCA) to Hold and Decreased Target from $16 to $4 on, May 25th, 2022.

Daniel has made no other calls on VRCA in the last 4 months.



There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Daniel's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Daniel


  • Kemp Dolliver of "Brookline Capital" Initiated at Strong Buy and Held Target at $20 on, Thursday, March 10th, 2022
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $18 on, Thursday, March 3rd, 2022

Publication Contributing Sources